Design of TLR2-ligand-synthetic long peptide conjugates for therapeutic vaccination of chronic HBV patients.
Dou Y, Jansen DTSL, van den Bosch A, de Man RA, van Montfoort N, Araman C, van Kasteren SI, Zom GG, Krebber WJ, Melief CJM, Woltman AM, Buschow SI.
Dou Y, et al. Among authors: buschow si.
Antiviral Res. 2020 Jun;178:104746. doi: 10.1016/j.antiviral.2020.104746. Epub 2020 Feb 17.
Antiviral Res. 2020.
PMID: 32081741
Free article.